NCT01298505 - A Study To Investigate The Safety And Toleration Of Multiple Oral Doses Of PF-03654764 In Combination With Fexofenadine In Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 4, 2010

Primary Completion Date

June 4, 2010

Study Completion Date

June 4, 2010

Conditions

Healthy

Interventions

DRUG

PF-03654764 2.5mg plus fexofenadine 60mg

PF-03654764 2.5mg plus fexofenadine 60mg twice daily for 7 days

DRUG

PF-03654764 5mg plus fexofenadine 60mg

PF-03654764 5mg plus fexofenadine 60mg twice daily for 7 days

DRUG

placebo

placebo given twice daily for 7 days

Trial Locations (1)

Pfizer Clinical Research Unit, Singapore